Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Palumbo

Showing results (201-210 of 218) with videos related to

Pageof 22
Sort By:
American Journal of Human Genetics|March 26, 1999
Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish populationI Aksentijevich, Y Torosyan, J Samuels, et al.
Stroke|September 2, 1999
1,4-Dihydropyridine calcium channel blockers inhibit plasma and LDL oxidation and formation of oxidation-specific epitopes in the arterial wall and prolong survival in stroke-prone spontaneously hypertensive ratsC Napoli, S Salomone, T Godfraind, et al.
Coronary Artery Disease|August 26, 1998
Effects of vitamin E and HMG-CoA reductase inhibition on cholesteryl ester transfer protein and lecithin-cholesterol acyltransferase in hypercholesterolemiaC Napoli, M Leccese, G Palumbo, et al.
Bone Marrow Transplantation|November 12, 2014
Outcome of children with high-risk acute myeloid leukemia given autologous or allogeneic hematopoietic cell transplantation in the aieop AML-2002/01 studyF Locatelli, R Masetti, R Rondelli, et al.
British Journal of Haematology|November 3, 2023
Natural history of Ras-associated autoimmune leukoproliferative disorder: A 20-year follow-up of a NRAS-mutated patient excluding a malignant progressionB Rivalta, E Attardi, C Cifaldi, et al.
Frontiers in Oncology|March 4, 2026
Siltuximab as a first-line therapy for idiopathic multicentric Castleman disease: a retrospective analysis based on the SiMuLa study of the Italian regional networkS Pelliccia, A Di Rocco, G Palumbo, et al.
Annals of Hematology|May 19, 2022
Daratumumab plus bortezomib or daratumumab plus lenalidomide as salvage therapy for patients with myeloma: initial follow-up of an Italian multicentre retrospective clinical experience by 'Rete Ematologica Pugliese'G Mele, N Cascavilla, N Di Renzo, et al.
Frontiers in Oncology|March 27, 2026
Correction: Siltuximab as a first-line therapy for idiopathic multicentric Castleman disease: a retrospective analysis based on the SiMuLa study of the Italian regional networkS Pelliccia, A Di Rocco, G Palumbo, et al.
Clinical Pharmacokinetics|July 18, 2019
A Semi-Mechanistic Population Pharmacokinetic/Pharmacodynamic Model of Bortezomib in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic LeukemiaJulie M Janssen, T P C Dorlo, D Niewerth, et al.
Annales De Biologie Clinique|January 1, 1996
Human thyroglobulin reference material (CRM 457). 1st Part: Assessment of homogeneity, stability and immunoreactivityU Feldt-Rasmussen, C Profilis, E Colinet, et al.
Pageof 22

Showing results (201-210 of 218) with videos related to

Sort By:
Pageof 22
American Journal of Human Genetics|March 26, 1999
Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish populationI Aksentijevich, Y Torosyan, J Samuels, et al.
Stroke|September 2, 1999
1,4-Dihydropyridine calcium channel blockers inhibit plasma and LDL oxidation and formation of oxidation-specific epitopes in the arterial wall and prolong survival in stroke-prone spontaneously hypertensive ratsC Napoli, S Salomone, T Godfraind, et al.
Coronary Artery Disease|August 26, 1998
Effects of vitamin E and HMG-CoA reductase inhibition on cholesteryl ester transfer protein and lecithin-cholesterol acyltransferase in hypercholesterolemiaC Napoli, M Leccese, G Palumbo, et al.
Bone Marrow Transplantation|November 12, 2014
Outcome of children with high-risk acute myeloid leukemia given autologous or allogeneic hematopoietic cell transplantation in the aieop AML-2002/01 studyF Locatelli, R Masetti, R Rondelli, et al.
British Journal of Haematology|November 3, 2023
Natural history of Ras-associated autoimmune leukoproliferative disorder: A 20-year follow-up of a NRAS-mutated patient excluding a malignant progressionB Rivalta, E Attardi, C Cifaldi, et al.
Frontiers in Oncology|March 4, 2026
Siltuximab as a first-line therapy for idiopathic multicentric Castleman disease: a retrospective analysis based on the SiMuLa study of the Italian regional networkS Pelliccia, A Di Rocco, G Palumbo, et al.
Annals of Hematology|May 19, 2022
Daratumumab plus bortezomib or daratumumab plus lenalidomide as salvage therapy for patients with myeloma: initial follow-up of an Italian multicentre retrospective clinical experience by 'Rete Ematologica Pugliese'G Mele, N Cascavilla, N Di Renzo, et al.
Frontiers in Oncology|March 27, 2026
Correction: Siltuximab as a first-line therapy for idiopathic multicentric Castleman disease: a retrospective analysis based on the SiMuLa study of the Italian regional networkS Pelliccia, A Di Rocco, G Palumbo, et al.
Clinical Pharmacokinetics|July 18, 2019
A Semi-Mechanistic Population Pharmacokinetic/Pharmacodynamic Model of Bortezomib in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic LeukemiaJulie M Janssen, T P C Dorlo, D Niewerth, et al.
Annales De Biologie Clinique|January 1, 1996
Human thyroglobulin reference material (CRM 457). 1st Part: Assessment of homogeneity, stability and immunoreactivityU Feldt-Rasmussen, C Profilis, E Colinet, et al.
Pageof 22